logo

For the Inventor, By the Inventor

Guttenberg, NJ, United States of America

Philip J Pye

This inventor holds 18 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Other. Active years: 1999-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip J Pye. Retrieved from https://idiyas.com/inventor/philip-j-pye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 72.2


Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Rahway, NJ (US) (2002)
  • Guttenberg, NJ (US) (1999 - 2013)

Company Filing History:

goldMedal16 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 834,659 
Other
 patents

Years Active: 1999-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
HIV Integrase Inhibitors
COX-2 Inhibitors
Chiral Bisphosphines
N-Alkylated Hydroxypyrimidinone
Intramolecular Glycosidation
Carbapenem Intermediates
Diaryl Pyridines
Oxazine Compounds
Synthesis Processes
Integrin Antagonists
Pyridine Derivatives
Pharmaceutical Intermediates
18 patents (USPTO):Explore Patents
1. 8357798 - Process for preparing N-alkylated hydroxypyrimidinone compounds (2013-01-22),
2. 7598264 - HIV integrase inhibitors (2009-10-06),
3. 6914144 - Process for preparing integrin antagonist intermediate (2005-07-05),
4. 6538134 - 4-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereof (2003-03-25),
5. 6469164 - Process for the synthesis of (2R, 2-alpha-R)-4-benzyl-2-[1-(3,5-bis (trifluoromethyl)phenyl)ethoxy]-1,4-oxazine-3-one (2002-10-22),
6. 6403793 - Intramolecular glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5- bis (trifluoromethyl) phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine (2002-06-11),
7. 6395894 - Process for the synthesis of carbapenem intermidiates, and compounds produced (2002-05-28),
8. 6369275 - Process for making diaryl pyridines useful as cox-2 inhibitors (2002-04-09),
9. 6252116 - Intermediates useful in a process for synthesizing COX-2 inhibitors (2001-06-26),
10. 6204387 - Process for making diaryl pyridines useful as COX-2 inhibitors (2001-03-20),
11. 6156895 - Process for preparing (2000-12-05),
12. 6130334 - Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 (2000-10-10),
13. 6127545 - Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 (2000-10-03),
14. 6043387 - Chiral bisphosphines (2000-03-28),
15. 6040450 - Process for making diaryl pyridines useful as cox-2-inhibitors (2000-03-21),

Title: The Inventor Philip J Pye: Revolutionizing Technology

Introduction: Philip J Pye, a distinguished inventor hailing from Guttenberg, NJ (US), has made significant contributions to the world of technology through his innovative creations and patents.

Latest Patents: Philip J Pye's latest patents include groundbreaking inventions in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Philip J Pye has established himself as a pioneer in the tech industry, holding numerous patents that have shaped the way we interact with modern technology.

Collaborations: Throughout his career, Philip J Pye has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Philip J Pye's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…